Weekly Market Summary 10 - 14 May 2021

My Bookmarksclose
You have no bookmarks currently
    Weekly Market Summary 10 - 14 May 2021
    Weekly Market Summary 10 - 14 May 2021
    17 May 2021

    Key Points

    • Wall Street ended lower in volatile week despite snapbacks on Thursday and Friday
    • Inflation worries remain the focus for investors as US prices and wages rise
    • Fed views rising prices as idiosyncratic due to reopening challenges

    The major Wall Street indices ended the week (10 - 14 May) lower with both the Dow and the S&P 500 down by more than 1% while the Nasdaq Composite fell back by over 2.3% – despite bouncing back on Thursday and Friday from steep losses earlier in a rollercoaster week which saw the Dow dip by nearly 1,200 points from Monday to Wednesday with the S&P 500 and the Nasdaq sliding by 4% and 5% over the period.

    Much of the volatility had stemmed from market concerns of the Fed underestimating the trajectory of inflation on the back of the latest producer price (PPI) and consumers price index (CPI) as well as news of hotel and restaurant chains such as McDonald’s having to raise wages in their hiring drives. Then, there was also the matter of a steep 10% increase in used cars and truck prices.

    It’s such developments that unnerve investors who fear that a more sustained pace in inflation may prompt the Fed to tighten monetary policy sooner than indicated in their official projections.

    Investors who place their bet on techs tend to be more jittery as growth in the sector are seen to be more likely to be impaired compared to cyclicals in light of the Center for Disease Control (CDC) announcement on Friday that vaccinated individuals do not need to wear masks – which will also make it harder for tech firms to sustain their current levels of earnings growth as lockdowns ease. The Nasdaq is currently 6% down from its peak a month ago.

    On the other hand, it is the oft-view of the Fed that it expects spikes in inflation will be transitory due to reopening bottlenecks in areas such as supply chains, wages, housing and rentals which was in part justified by flat on-month retail sales for April and declines in both iron ore and copper prices by nearly 2% for the week.

    Other economists are also of the view that the spike in inflation for April was due to the low base a year ago when prices collapsed from the onset of the virus and subsequent lockdowns.

    In short, despite the current tantrums in equities, the US central bank does not see any spiral or broad-based inflation looming on the horizon – other than idiosyncratic cases of rising prices due to reopening challenges such as those stemming from shifts in labour market and supply squeezes ranging from shipping containers and bulk freight to semiconductor chips and lumber for housing.

    Fed governor Lael Brainard had tried to assuage the market saying that production-related wrinkles would be ironed out over time and that “supply-demand imbalances” in the in-person services sector would also be resolved as vaccination rollouts continue – which will reduce “virus-related impediments” facing businesses due to lingering concerns over workplace health and safety, gaps in childcare and public mobility.

    Whether reflation will be benign and orderly or will it hit some unexpected overheating and prolonged bumps that could become disorderly for markets, investors will be looking at clues and cues this coming week from US housing data and earnings of major retailers, Walmart and Home Depot as well as minutes from the last FOMC meeting and comments from Fed policy makers. Other data include Markit manufacturing and services PMIs and initial job claims. Investors will be watching to see if the inflationary trend is also taking hold in Europe from price data on Wednesday.

    In the meantime, the rotation to emerging markets continued to face headwinds amid the resurgent waves of virus made worse by more infectious variants which have triggered renewed restrictions and lockdowns with the World Health Organisation (WHO) warning of a more deadly pandemic if safeguards and expanded vaccination programmes are not in place leading to more disruptions.

     

    This publication shall not be copied or disseminated, or relied upon by any person for whatever purpose. The information herein is given on a general basis without obligation and is strictly for information only. This publication is not an offer, solicitation, recommendation or advice to buy or sell any investment product, including any collective investment schemes or shares of companies mentioned within. Although every reasonable care has been taken to ensure the accuracy and objectivity of the information contained in this publication, UOB Asset Management Ltd ("UOBAM") and its employees shall not be held liable for any error, inaccuracy and/or omission, howsoever caused, or for any decision or action taken based on views expressed or information in this publication. The information contained in this publication, including any data, projections and underlying assumptions are based upon certain assumptions, management forecasts and analysis of information available and reflects prevailing conditions and our views as of the date of this publication, all of which are subject to change at any time without notice. Please note that the graphs, charts, formulae or other devices set out or referred to in this document cannot, in and of itself, be used to determine and will not assist any person in deciding which investment product to buy or sell, or when to buy or sell an investment product. UOBAM does not warrant the accuracy, adequacy, timeliness or completeness of the information herein for any particular purpose, and expressly disclaims liability for any error, inaccuracy or omission. Any opinion, projection and other forward-looking statement regarding future events or performance of, including but not limited to, countries, markets or companies is not necessarily indicative of, and may differ from actual events or results. Nothing in this publication constitutes accounting, legal, regulatory, tax or other advice. The information herein has no regard to the specific objectives, financial situation and particular needs of any specific person. You may wish to seek advice from a professional or an independent financial adviser about the issues discussed herein or before investing in any investment or insurance product. Should you choose not to seek such advice, you should consider carefully whether the investment or insurance product in question is suitable for you.

    Stay up-to-date with our latest investment insights

    Sign up now